Clinical Trial Update: Tart Cherry, Metabolic Syndrome, and Cardiovascular Risk [Phase 2]

View source ↗

Summary

A Phase 2 trial led by Florida State University evaluated tart cherry supplementation for metabolic syndrome and cardiovascular risk; the study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus
• Metabolic Syndrome

Drugs mentioned

• Tart Cherry

Snippet

Sponsor: Florida State University | Conditions: Metabolic Syndrome, Cardiovascular Diseases | Phase 2 | Status: COMPLETED